| 摘要: |
| 靛玉红是来源于中药青黛的双吲哚生物碱,对多种癌症均表现出抗癌活性,尤其是对慢性粒细胞白血病。本文从靛玉红的结构修饰入手,并从细胞水平,与癌症相关的蛋白,靶点和通路等方面对靛玉红及其衍生物的抗肿瘤机制进行综述,为具有优秀抗肿瘤活性的新型靛玉红衍生物的研发提供依据。 |
| 关键词: 靛玉红 靛玉红衍生物 结构修饰 抗肿瘤 |
| DOI:10.13506/j.cnki.jpr.2026.02.016 |
| 基金项目:天津市卫生健康委员会中医中西医结合科研课题项目(No.2023077) |
|
出版日期:2026-02-25
|
|
| Research progress on the anti-tumor mechanism of indirubin and its derivatives |
| SONG Gaoping,CHEN Wenmin,YU Pengxin,DUAN Lili |
| (School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China) |
| Abstract: |
| Indirubin, a kind of bis-indole alkaloid, is derived from the traditional Chinese medicine Indigofera tinctoria L, and exhibits anti-tumor activities against various cancers, especially chronic myelocytic leukemia. This paper describes the structural modification of Indirubin and relative anti-tumor mechanisms from the cellular level, cancer-related proteins, targets, and signaling pathways, providing a basis for the development of novel Indirubin derivatives with excellent anti-tumor activity. |
| Key words: Indirubin Indirubin derivatives Structural modification Anti-tumor |